Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hermann Haller

Showing results (541-550 of 570) with videos related to

Pageof 57
Sort By:
Journal of the American College of Cardiology|October 2, 2010
Novel baroreflex activation therapy in resistant hypertension: results of a European multi-center feasibility studyIngrid J M Scheffers, Abraham A Kroon, Jürg Schmidli, et al.
International Journal of Biological Sciences|September 17, 2025
Dectin-1 is Pathogenic in Chronic Kidney Disease by Promoting Macrophage Infiltration and Transition to MyofibroblastLingling Shen, Jingyi Li, Anqi Zhang, et al.
Diabetes, Obesity & Metabolism|March 24, 2022
Cost of healthcare utilization associated with incident cardiovascular and renal disease in individuals with type 2 diabetes: A multinational, observational study across 12 countriesAnna Norhammar, Johan Bodegard, Jan W Eriksson, et al.
Blood|July 31, 2020
The integrin-linked kinase is required for chemokine-triggered high-affinity conformation of the neutrophil β2-integrin LFA-1Andreas Margraf, Giulia Germena, Hannes C A Drexler, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 28, 2017
Therapeutic miR-21 Silencing Ameliorates Diabetic Kidney Disease in MiceMalte Kölling, Tamas Kaucsar, Celina Schauerte, et al.
Critical Care (London, England)|May 13, 2022
Clinical and biochemical endpoints and predictors of response to plasma exchange in septic shock: results from a randomized controlled trialKlaus Stahl, Philipp Wand, Benjamin Seeliger, et al.
Plos One|August 21, 2018
Blood pressure control in chronic kidney disease: A cross-sectional analysis from the German Chronic Kidney Disease (GCKD) studyMarkus P Schneider, Karl F Hilgers, Matthias Schmid, et al.
Plos One|September 14, 2018
Correction: Blood pressure control in chronic kidney disease: A cross-sectional analysis from the German Chronic Kidney Disease (GCKD) studyMarkus P Schneider, Karl F Hilgers, Matthias Schmid, et al.
Kidney International|June 25, 2018
Enhanced activation of interleukin-10, heme oxygenase-1, and AKT in C5aR2-deficient mice is associated with protection from ischemia reperfusion injury-induced inflammation and fibrosisAnja Thorenz, Katja Derlin, Christoph Schröder, et al.
American Journal of Physiology. Renal Physiology|August 18, 2020
Early antihypertensive treatment and ischemia-induced acute kidney injuryRobert Greite, Katja Derlin, Bennet Hensen, et al.
Pageof 57

Showing results (541-550 of 570) with videos related to

Sort By:
Pageof 57
Journal of the American College of Cardiology|October 2, 2010
Novel baroreflex activation therapy in resistant hypertension: results of a European multi-center feasibility studyIngrid J M Scheffers, Abraham A Kroon, Jürg Schmidli, et al.
International Journal of Biological Sciences|September 17, 2025
Dectin-1 is Pathogenic in Chronic Kidney Disease by Promoting Macrophage Infiltration and Transition to MyofibroblastLingling Shen, Jingyi Li, Anqi Zhang, et al.
Diabetes, Obesity & Metabolism|March 24, 2022
Cost of healthcare utilization associated with incident cardiovascular and renal disease in individuals with type 2 diabetes: A multinational, observational study across 12 countriesAnna Norhammar, Johan Bodegard, Jan W Eriksson, et al.
Blood|July 31, 2020
The integrin-linked kinase is required for chemokine-triggered high-affinity conformation of the neutrophil β2-integrin LFA-1Andreas Margraf, Giulia Germena, Hannes C A Drexler, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 28, 2017
Therapeutic miR-21 Silencing Ameliorates Diabetic Kidney Disease in MiceMalte Kölling, Tamas Kaucsar, Celina Schauerte, et al.
Critical Care (London, England)|May 13, 2022
Clinical and biochemical endpoints and predictors of response to plasma exchange in septic shock: results from a randomized controlled trialKlaus Stahl, Philipp Wand, Benjamin Seeliger, et al.
Plos One|August 21, 2018
Blood pressure control in chronic kidney disease: A cross-sectional analysis from the German Chronic Kidney Disease (GCKD) studyMarkus P Schneider, Karl F Hilgers, Matthias Schmid, et al.
Plos One|September 14, 2018
Correction: Blood pressure control in chronic kidney disease: A cross-sectional analysis from the German Chronic Kidney Disease (GCKD) studyMarkus P Schneider, Karl F Hilgers, Matthias Schmid, et al.
Kidney International|June 25, 2018
Enhanced activation of interleukin-10, heme oxygenase-1, and AKT in C5aR2-deficient mice is associated with protection from ischemia reperfusion injury-induced inflammation and fibrosisAnja Thorenz, Katja Derlin, Christoph Schröder, et al.
American Journal of Physiology. Renal Physiology|August 18, 2020
Early antihypertensive treatment and ischemia-induced acute kidney injuryRobert Greite, Katja Derlin, Bennet Hensen, et al.
Pageof 57